165 related articles for article (PubMed ID: 37031501)
1. Geographic disparities in the care and outcomes in adult chronic immune thrombocytopenia.
Wall E; Podstawka J; Patterson JM; Bolster L; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2023 May; 225():87-94. PubMed ID: 37031501
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion practices in immune thrombocytopenia related hospitalizations.
Goel R; Chopra S; Tobian AAR; Ness PM; Frank SM; Cushing M; Vasovic L; Kaicker S; Takemoto C; Josephson CD; Nellis M; Bussel J; Krishnamurti L
Transfusion; 2019 Jan; 59(1):169-176. PubMed ID: 30520045
[TBL] [Abstract][Full Text] [Related]
4. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.
Lozano ML; Revilla N; Gonzalez-Lopez TJ; Novelli S; González-Porras JR; Sánchez-Gonzalez B; Bermejo N; Pérez S; Lucas FJ; Álvarez MT; Arilla MJ; Perera M; do Nascimento J; Campos RM; Casado LF; Vicente V
Ann Hematol; 2016 Jun; 95(7):1089-98. PubMed ID: 27098812
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
6. Hospitalizations in pediatric patients with immune thrombocytopenia in the United States.
Tarantino MD; Danese M; Klaassen RJ; Duryea J; Eisen M; Bussel J
Platelets; 2016 Jul; 27(5):472-8. PubMed ID: 26941022
[TBL] [Abstract][Full Text] [Related]
7. Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.
Ammad Ud Din M; Mahmud A; Mostafa M; Shahzad M; Liaqat H; Pinilla-Ibarz J; Jaglal M
Ann Hematol; 2023 Apr; 102(4):889-895. PubMed ID: 36781419
[TBL] [Abstract][Full Text] [Related]
8. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the impact and burden of illness of adult chronic ITP in the US.
Saleh MN; Fisher M; Grotzinger KM
Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
[TBL] [Abstract][Full Text] [Related]
10. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
[TBL] [Abstract][Full Text] [Related]
11. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
12. Management of major bleeds in patients with immune thrombocytopenia.
Mithoowani S; Cervi A; Shah N; Ejaz R; Sirotich E; Barty R; Li N; Nazy I; Arnold DM
J Thromb Haemost; 2020 Jul; 18(7):1783-1790. PubMed ID: 32219982
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.
Ahmed R; Devasia AJ; Viswabandya A; Lakshmi KM; Abraham A; Karl S; Mathai J; Jacob PM; Abraham D; Srivastava A; Mathews V; George B
Ann Hematol; 2016 Sep; 95(9):1429-34. PubMed ID: 27370992
[TBL] [Abstract][Full Text] [Related]
14. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
[TBL] [Abstract][Full Text] [Related]
15. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
Li S; Molony JT; Cetin K; Wasser JS; Altomare I
Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
[TBL] [Abstract][Full Text] [Related]
16. Clinical variations between three different causes of thrombocytopenia.
Akin S; Haznedaroglu IC
Niger J Clin Pract; 2021 Jan; 24(1):17-20. PubMed ID: 33473020
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries.
Liang Y; Rascati K; Richards K
Curr Med Res Opin; 2021 Aug; 37(8):1315-1322. PubMed ID: 33910428
[TBL] [Abstract][Full Text] [Related]
18. Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia.
Taparia K; Wall E; Arnold DM; Sun HL
J Thromb Haemost; 2022 Sep; 20(9):2119-2126. PubMed ID: 35751575
[TBL] [Abstract][Full Text] [Related]
19. Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods-One-Center Experience.
Lebowa W; Zdziarska J; Sacha T
Hamostaseologie; 2023 Apr; 43(2):132-141. PubMed ID: 35654406
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA.
Finianos A; Mujadzic H; Peluso H; Mujadzic T; Taher A; Abougergi MS
Ann Hematol; 2021 Apr; 100(4):941-952. PubMed ID: 33560468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
